Don't settle for ordinary quarterly reports.
I take a look at three companies that beat market expectations every week, since I believe that it's the biggest factor in a stock beating the market. Leaving Wall Street's pros with stunned expressions can be a good thing. It usually means that the companies have more in the tank than analysts figured. Capital appreciation typically follows.
Let's take a look at a few companies that humbled the prognosticators over the past few trading days.
We can start with Mosaic
Blood-test specialist Immucor
Finally, we have Robbins & Myers
It's important to keep watching the companies that surpass expectations. Over time, it will be a lucrative experience for investors as the market rewards the overachievers. That's the kind of surprise that we look for in the Rule Breakers newsletter service. Want in? Check out a 30-day trial subscription.
Either way, come back next Monday to learn about more stocks that blew the market away.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.
Longtime Fool contributor Rick Munarriz is a fan of toppers. He does not own shares in any of the stocks in this column. He is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early. The Fool has a disclosure policy.
More from The Motley Fool
Potash Stock or Agrium Stock? 1 Analyst Says Both
TD Securities likes this merger -- and thinks you'll like Nutrien stock even better.
Here's Why Mosaic Co Dropped 12.7% in August
Management reduced its full-year 2017 financial guidance. Here's what you need to know.
Why Rising Lithium Production Could Crush Fertilizer Stocks
Lithium stocks could continue rising as production increases, but it may come at the expense of potash producers. It could even bankrupt one investor favorite.